Search results
OncoBeta introduces Rhenium-SCT for non-melanoma skin cancer patients at Hospital Universitario 12...
Digital Journal· 1 day agoJun. 20, 2024 / PRZen / MADRID -- OncoBeta®, a leading medical device company specialising in innovative epidermal radioisotope therapies, today announced Hospital Universitario 12 de Octubre ...
Uracil levels could indicate oral cancer
Nature· 4 days agoAltered pyrimidine metabolism components may be a disease marker
An overview of different types of lung cancer: Causes and treatment
Medical News Today· 3 days agoThe two main types of lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). While anyone can get lung cancer, the risk is much higher for smokers and those experiencing ...
Interdisciplinary team maps role of P. gingivalis in drug resistance
Medical Xpress· 4 days agoBesim Ogretmen, Ph.D., SmartState Endowed Chair in Lipidomics and Drug Discovery in the College of Medicine, and Ӧzlem Yilmaz, D.D.S., Ph.D., a professor, clinician-scientist and microbiologist ...
Compugen (NASDAQ:CGEN) Upgraded to Buy by StockNews.com
ETF DAILY NEWS· 1 day agoStockNews.com upgraded shares of Compugen (NASDAQ:CGEN – Free Report) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning. Separately, Truist Financial ...
Kevin Jonas has basal cell carcinoma – here’s what you should know about this form of skin cancer
The Conversation· 2 days agoKevin Jonas has become the latest celebrity to share news of a skin cancer diagnosis. The 36-year-old singer and actor took to Instagram to reveal he’d recently been diagnosed basal cell carcinoma ...
ALX Oncology Holdings Inc. (NASDAQ:ALXO) CFO Peter S. Garcia Acquires 12,000 Shares
ETF DAILY NEWS· 4 days agoALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) CFO Peter S. Garcia acquired 12,000 shares of the firm’s stock in a transaction on Thursday, June 13th. The stock was purchased at ...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks· 3 days agoFree Report) is one of the few top biotech companies that has outperformed the industry year to date. Regeneron’s efforts to diversify its portfolio have impressed its investors, even as lead ...
Q1 2025 EPS Estimates for Replimune Group, Inc. (NASDAQ:REPL) Boosted by Wedbush
ETF DAILY NEWS· 3 days agoReplimune Group, Inc. (NASDAQ:REPL – Free Report) – Analysts at Wedbush boosted their Q1 2025 earnings per share (EPS) estimates for Replimune Group in a research note issued on Thursday, June ...
